Macrophages play a pivotal role in innate immune responses to pathogens via toll-like receptors. We previously demonstrated that aryl hydrocarbon receptor (Ahr) in combination with signal transducer and activator of transcription 1 (Stat1) negatively regulates pro-inflammatory cytokine production by inhibiting nuclear factor-kB activation in macrophages after LPS stimulation. Here, we show that Ahr also negatively regulates production of the pro-inflammatory cytokine IL-6 by suppressing histamine production in macrophages stimulated by LPS. We found that Ahr-Sp1 complex, independent of Stat1, represses histidine decarboxylase expression by inhibiting LPS-induced Sp1 phosphorylation on Ser residues in macrophages; this leads to suppression of histamine production. Moreover, we found that loratadine and chlorpromazine, histamine 1 receptor (H1R) antagonists, more effectively impair the production of LPS-induced IL-6 than that of other inflammatory cytokines in Ahr 2/2 macrophages. Collectively, these results demonstrate that Ahr negatively regulates IL-6 production via H1R signaling through the suppression of histamine production in macrophages following LPS stimulation.
Introduction
Histamine, which is synthesized by histidine decarboxylase (HDC), is a chemical mediator that causes various physiological and pathological reactions, including smooth muscle contraction, vasodilation, gastric acid secretion, neurotransmission in the central nervous system, allergic reactions and immune regulation (1) (2) (3) . These reactions are induced in various cell types via histamine 1-4 receptors (H124R), which are G protein-coupled receptors. In mast cells and basophils, histamine is mainly stored in intracellular vesicles and is transiently released when these cells degranulate in response to immunologic or non-immunologic stimuli; elicits allergic inflammation (4) . Histamine is also produced by macrophages and T lymphocytes, in which it is readily secreted and enhances the immune response (5, 6) . The expression patterns of histamine receptors play a role in the regulation of immune responses to histamine. It has been reported that macrophages express H1R, H2R and H4R (7) and histamine plays a role not only in immunoregulation (8) but also in inflammatory functions via these receptors. In particular, H1R activation enhances inflammatory functions in immune cells. It has been reported that H1R activation induces the production of IFN-c in T cells (9) and also elevates the production of pro-inflammatory cytokines in the different types of cells, such as macrophages and dendritic cells (10) (11) (12) (13) . More recently, it has been shown that histamine activates nuclear factor-jB (NF-jB) and c-Jun N-terminal kinase (JNK) via H1R (14, 15) .
Macrophages are essential players in the innate immune response to pathogens, in which they recognize LPS, a component of bacterial cell membranes, via toll-like receptor 4 (TLR4). In response to TLR4 signaling, macrophages produce pro-inflammatory cytokines, such as IL-6, IL-12 and tumor necrosis factor (TNF)-a in inflammatory sites. In mice, LPS also enhances the levels of HDC expression in liver, spleen, lungs and bone marrow, sites at which significant numbers of macrophages are located (16) . Moreover, it has been reported that mast cells do not contribute to the induction of HDC by LPS (17) . Higuchi et al. (18) reported that histamine secreted from macrophages might lead to atherosclerosis. Ghosh et al. (19) also reported that histamine derived from non-mast cells, such as macrophages, played a pivotal role in angiogenesis. Thus, the role of histamine secreted by macrophages in inflammatory diseases has been extensively studied. However, it remains to be understood how the activity of HDC expression is regulated in macrophages.
It has been reported that Sp1 is involved in LPS-induced HDC expression in macrophages (20) . It is a transcription factor that is expressed in different tissues. Sp1 binds to GC box regions in thousands of genes via three contiguous C 2 H 2 zinc finger domains, which regulates transcription of genes involved in metabolism, cell growth, differentiation, angiogenesis and apoptosis (21) . Post-translational modifications of Sp1, including phosphorylation, glycosylation, acetylation, sumoylation and ubiquitylation, influence its transcriptional activity and stability (22) . Sp1 also regulates numerous genes through interaction with other proteins. For instance, an interaction between Sp1 and aryl hydrocarbon receptor (Ahr) is important for the regulation of the cytochrome P-450 1A1 (CYP1A1) gene, which produces an enzyme with the ability to metabolize drugs (23) .
Ahr is a ligand-activated transcription factor that belongs to the basic helix-loop-helix-PER-ARNT-SIM family (24, 25) . It is known that 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and 3-methylcholanthrene (3MC) are strong activators of Ahr. Upon binding of such ligands, Ahr undergoes a conformational change, translocates to the nucleus and dimerizes with Ahr nuclear translocator (Arnt). Within the nucleus, the Ahr/Arnt heterodimer binds to xenobiotic responsive element (XRE) sequences, which causes a variety of toxicological effects (26) (27) (28) . Ahr also plays the role of a liganddependent E3 ubiquitin ligase (29) . Thus, Ahr has dual functions in transcriptional regulation and in selective protein degradation. Moreover, we have recently reported that Ahr is involved in immune regulation (30) (31) (32) (33) .
In this study, we demonstrate that Ahr inhibits LPSinduced HDC expression and histamine production in macrophages through interaction with Sp1. In addition to our previous report (32) , we also provide evidence that Ahr negatively regulates another pathway of IL-6 production through suppression of histamine production in macrophages.
Methods

Mice
C57BL/6J wild-type (WT) mice were purchased from Charles Japan (Ibaraki, Osaka, Japan). Ahr-deficient (Ahr À/À ) mice (C57BL/6 background) and signal transducer and activator of transcription 1 (Stat1)-deficient (Stat1 À/À ) mice (C57BL/6 background) were provided by Dr Yoshiaki Fujii-Kuriyama (Tokyo Medical and Dental University, Bunkyo-ku, Tokyo, Japan) and Dr Tetsuji Naka (National Institute of Biomedical Innovation, Ibaraki, Osaka, Japan), respectively. All mice were maintained under specific pathogen-free conditions. All animal experiments were performed in accordance with protocols approved by the Institutional Animal Care and Use Committee of the Graduate School of Frontier Biosciences, Osaka University.
Cell culture
Peritoneal macrophages were prepared as previously described (32) . Thioglycolate-elicited peritoneal macrophages were cultured in RPMI 1640 with 10% FCS (Sigma-Aldrich, St Louis, MO, USA), 100 lg ml À1 streptomycin and 100 U ml À1 penicillin G (Nakalai, Kyoto, Japan). RAW/Ahr cells (RAW 264.7 cells over-expressing Ahr) and RAW/Neo cells (as control) were established as previously described (32) . These cells were maintained in the presence of 500 lg ml À1 G418 disulfate (Nakalai).
Reagents
LPS (Escherichia coli) were purchased from Sigma-Aldrich. Loratadine and chlorpromazine were purchased from Axon Medchem (Groningen, Netherlands) and LKT Laboratories (St Paul, MN, USA), respectively.
Cytokine ELISA
Levels of mouse IL-6, IL-12, TNF-a and IL-10 from culture supernatants were measured using ELISA according to the manufacturer's instructions (R&D Systems, Minneapolis, MN, USA).
Determination of histamine content
After incubation with LPS, histamine content of culture supernatants was determined as described by Yamatodani et al. (34) and by a histamine ELISA kit (IBL, Hamburg, Germany).
Immunoprecipitation and Western blotting
WT macrophages or RAW264.7 cells (RAW/Neo and RAW/ Ahr cells) were cultured with 1 lg ml À1 LPS for 24 h and then lysed with lysis buffer [1% NP-40, 20 mM, pH 7.5, TrisHCl, 150 mM NaCl, 0.5 mM DTT and 1% protease inhibitor cocktail (Nakalai), 10 mM Na 2 VO 4 (Sigma)]. Ahr or Sp1 was immunoprecipitated with anti-Ahr (BIOMOL International L.P., Plymouth Meeting, PA, USA) or anti-Sp1 (Santa Cruz Biotechnology, Santa Cruz, CA, USA) antibody and then subjected to SDS-PAGE. Whole-cell lysates and the immunocomplex were analyzed by Western blotting using anti-Sp1, anti-Ahr, anti-phosphoSerine (Invitrogen, Carlsbad, CA, USA), anti-phosphoThreonine (Cell Signaling Technology, Danvers, MA, USA), anti-phosphoTyrosine (Invitrogen), or anti-G3PDH (Santa Cruz Biotechnology) antibodies.
Luciferase assay
RAW/Neo and RAW/Ahr cells were co-transfected with 1 lg of HDC reporter plasmid (pGLm-1099), which was provided by Dr Hiroshi Ohtsu (School of Engineering, Tohoku University, Sendai, Japan) and 0.1 lg of pRL-TK for use as an internal control reporter. Cells were stimulated with 1 lg ml À1 LPS for 24 h and lysed with luciferase lysis reagents (Promega, Madison, WI, USA). Luciferase activity was determined with a commercial dual-luciferase reporter assay system (Promega) according to the manufacturer's instructions. Relative light units of Firefly luciferase activity were normalized with Renilla luciferase activity.
TransAM assay
RAW/Neo and RAW/Ahr cells or WT and Ahr À/À macrophages were stimulated with 1 lg ml À1 LPS for 24 h. Nuclear extraction was performed with a nuclear extraction kit (Active Motif, Carlsbad, CA, USA); 10 lg of nuclear extraction protein was used to assess Sp1-binding activity using the Sp1 TransAM Assay (Active Motif) according to the manufacturer's instructions.
Chromatin immunoprecipitation assay
Chromatin immunoprecipitation (ChIP) assay was performed essentially according to Millipore's protocol (Billerica, MA, USA). In brief, RAW/Neo and RAW/Ahr cells were stimulated with 1 lg ml À1 LPS for 24 h and then fixed with formaldehyde for 10 min at 37°C. The cells were lysed, sheared by sonication and incubated overnight with anti-Sp1 or anti-IgG (Santa Cruz Biotechnology) antibody, followed by incubation with protein A-agarose saturated with salmon sperm DNA (Vector Laboratories, Burlingame, CA, USA). Precipitated DNAs were analyzed by reverse transcription-PCR (35 cycles) using primers 5#-CCCCGTCCCTACTATCTCCC-3# (forward) and 5#-GACACGTGAGGGACCGTCGG-3# (reverse) for the GC box sequence in the mouse HDC promoter.
Reverse transcription-PCR
After stimulation with 1 lg ml À1 LPS for the indicated time, cells were washed with ice-cold PBS and scraped with a rubber policeman. Total RNA was extracted using RNeasy (Qiagen, Valencia, USA) and cDNA was prepared as previously described (30) . The primers used for amplification of the HDC cDNA were: (forward) 5#-GGATCCAAGATCAGATTTCTACCTG-TGGAC-3# and (reverse) 5#-GTCGACGACATGTGCTTGAAGA TTCTTCAC-3#. PCR was performed for 30 cycles: denaturation at 94°C for 30 s, annealing at 56°C for 1 min and extension at 72°C for 2 min. The primers used for amplification of the G3PDH cDNA were (forward) 5#-TCCACCACCCTGTTG-CTGTA-3# and (reverse) 5#-ACCACAGTCCATGCCATCAC-3#. PCR was performed for 25 cycles: denaturation at 94°C for 45 s, annealing at 58°C for 30 s and extension at 72°C for 30 s. Under these conditions, the level of each mRNA could be determined semi-quantitatively.
Quantitative real-time PCR
Total RNA was prepared by RNeasy (Qiagen) and cDNA was prepared as previously described (30) . The mouse HDC probe (Gene Expression Assays: Mm00456104_m1; Applied Biosystems, Carlsbad, CA, USA) was used and the mouse probes of H1R, H2R and G3PDH were prepared as described elsewhere (35) . Quantitative real-time PCR (qPCR) was carried out in an ABI PRISM 7900 HT (Applied Biosystems). Cycling conditions were 50°C for 2 min and 95°C for 10 min, followed by 40 cycles of 95°C for 15 s and 60°C for 1 min. We applied the comparative DDCt method normalized to G3PDH for HDC, H1R and H2R mRNA quantitative analysis. The value of unstimulated WT macrophages was set at one (as control) and was used to calculate the fold change in the other samples.
Statistical analysis
The student's t-test was used to analyze data for statistically significant differences. Values of P < 0.05 were regarded as statistically significant.
Results
Ahr inhibits LPS-induced HDC mRNA levels and histamine production in macrophages
We previously reported that Ahr is induced by LPS in macrophages and that it negatively regulates innate immune responses by cooperating with Stat1 (32) . To examine the role of Ahr in macrophages activated by LPS, we used a DNA microarray to compare mRNA levels in WT macrophages with those in Ahr À/À macrophages after LPS stimulation. The gene expression profiling analysis showed that the level of HDC mRNA in Ahr À/À macrophages was significantly elevated, compared with that in WT macrophages after treatment with LPS (data not shown). Therefore, we compared LPS-induced HDC mRNA levels in WT macrophages and RAW/Ahr cells (RAW264.7 cells over-expressing Ahr) with those in Ahr À/À macrophages and RAW/Neo cells, using reverse transcription-PCR (RT-PCR) and qPCR, respectively. As shown in Fig. 1(A-D) , HDC mRNA levels after stimulation with LPS were significantly suppressed in WT macrophages and RAW/Ahr cells, compared with those in Ahr À/À macrophages and RAW/Neo cells, respectively. These results indicate that Ahr regulates LPS-induced HDC expression in macrophages. To examine whether Ahr inhibits histamine production secreted from activated macrophages, we next measured the levels of histamine produced from WT and Ahr À/À macrophages or RAW/Neo and RAW/Ahr cells after LPS treatment as described in Methods. LPSinduced histamine was significantly elevated in RAW/Neo cells and Ahr À/À macrophages, compared with that in RAW/ Ahr cells and WT macrophages, respectively ( Fig. 1E and F). Intracellular histamine was not detected (data not shown). These results suggest that Ahr inhibits the secretion of histamine from activated macrophages by suppressing LPS-induced HDC expression.
Ahr attenuates LPS-induced Sp1 transcriptional activity at the mouse HDC promoter
It has been reported that Sp1 is activated by LPS and induces HDC expression in RAW 264.7 cells (20) . To determine whether Ahr directly regulates Sp1 activation after stimulation with LPS, we examined whether Ahr interacts with Sp1 in activated macrophages using Western blot analysis and immunoprecipitation (IP). As shown in Fig. 2(A) , Ahr physically interacted with Sp1 in activated macrophages. We next investigated the effects of Ahr on LPS-induced HDC activation using luciferase reporter assay. RAW/Neo and RAW/Ahr cells were transiently transfected with a reporter plasmid containing the HDC promoter (pGLm-1099), and luciferase activity was measured. LPS-induced HDC activation was significantly suppressed in RAW/Ahr cells, compared with that in RAW/Neo Negative regulation of LPS-induced IL-6 production by aryl hydrocarbon receptor 639 cells (Fig. 2B) . Next, we compared LPS-induced Sp1 DNAbinding activity in WT macrophages and RAW/Ahr cells with that in Ahr À/À macrophages and RAW/Neo cells using TransAm assay. The activity of Sp1 DNA binding in WT macrophages and RAW/Ahr cells was attenuated compared to that in Ahr À/À macrophages and RAW/Neo cells, respectively ( Fig. 2C and D) . Furthermore, we performed ChIP assay to determine whether Ahr affects the ability of Sp1 to bind to the GC box sequence in the mouse HDC promoter region. As shown in Fig. 2(E) , the Sp1 DNA-binding activity in RAW/Ahr cells was significantly suppressed, compared with that in RAW/Neo cells. These results suggest that Ahr impairs Sp1 DNA-binding capacity in the mouse HDC promoter region by directly associating with Sp1, which leads to the attenuation of LPS-induced Sp1 transcriptional activity.
Ahr influences the levels of Sp1 phosphorylation on Ser residues but not Sp1 protein level in RAW264.7 cells stimulated with LPS As shown in Fig. 2 , LPS-induced Ahr attenuated the ability of Sp1 to bind to the GC box region in the HDC promoter.
However, it is not clear how Ahr decreases Sp1 DNA-binding activity after stimulation with LPS. We first compared the level of Sp1 protein in RAW/Neo cells with that in RAW/Ahr cells after stimulation with LPS. As shown in Fig. 3(A) , LPS did not affect the level of Sp1 protein in either RAW/Neo or RAW/Ahr cells. As it has been reported that the phosphorylation of Sp1 influences its DNA-binding activity (21), we next investigated whether Ahr regulates Sp1 phosphorylation in RAW/Neo and RAW/Ahr cells stimulated with LPS. Using IP and Western blot analysis, we found that the levels of LPS-induced Sp1 phosphorylation on Ser residues in RAW/ Ahr cells were significantly suppressed, compared with those in RAW/Neo cells. In contrast, there was no difference in the levels of LPS-induced Sp1 phosphorylation on Thr residues in RAW/Neo and RAW/Ahr cells and Tyr residues in Sp1 were not phosphorylated by LPS in either cell type (Fig. 3B) . These results suggest that Ahr attenuates the ability of Sp1 to bind to the GC box region in the HDC promoter by decreasing LPS-induced Sp1 phosphorylation on Ser residues. À1 LPS stimulation were examined using qPCR. (C and D) Data show means 6 SD of three independent experiments (*P < 0.02, **P < 0.005). The levels of histamine secreted from WT and Ahr À/À macrophages (E) or RAW/Neo and RAW/Ahr cells (F) at the indicated times after 1 lg ml À1 LPS treatment were measured with an HPLC method (34) and a histamine ELISA kit. (E and F) Data show means 6 SD of three independent experiments (*P < 0.05, **P < 0.005, ***P < 0.001).
Stat1 deficiency does not affect LPS-induced HDC mRNA levels and histamine production in macrophages
We previously demonstrated that Ahr-Stat1 complex regulates LPS-induced transcription of the IL-6 gene in macrophages by interacting with NF-jB (32) . To determine whether Stat1 regulates LPS-induced transcription of the HDC gene, we compared the level of LPS-induced HDC mRNA in Stat1 À/À macrophages with that of WT macrophages, using RT-PCR and qPCR. As shown in Fig. 4 , Stat1 deficiency had no influence on HDC mRNA levels or histamine secretion after stimulation with LPS. This result suggests that the regulation of HDC mRNA expression by Ahr is Stat1 independent.
H1R antagonists inhibit LPS-induced IL-6 production in Ahr
À/À macrophages in a dose-dependent manner Our previous report demonstrated that Stat1 deficiency and Ahr deficiency augment the production of LPS-induced proinflammatory cytokines in macrophages (32) . To examine whether LPS-induced histamine regulates the production of pro-and anti-inflammatory cytokines via H1R in macrophages, we measured the production of IL-6, IL-12, TNF-a and IL-10 in WT and Ahr À/À macrophages ( Fig. 5A and C) as well as in WT and Stat1 À/À macrophages ( Fig. 5B and D) stimulated by LPS after these cells were exposed to loratadine or chlorpromazine, H1R antagonists, respectively. The two antagonists inhibited LPS-induced IL-6 production in Ahr À/À macrophages in a dose-dependent manner, whereas LPS-induced IL-12, TNF-a and IL-10 production was less sensitive to the two chemicals ( Fig. 5A and C) . Loratadine and chlorpromazine at 1 3 10 À5 or 2 3 10 À5 M also impaired LPS-induced IL-6 production in Stat1 À/À or WT macrophages, whereas the two blockers did not critically influence the levels of IL-12, IL-10 and TNF-a (Fig. 5B and D) . Moreover, H1R antagonists did not affect viability of macrophages at high concentrations (Supplementary Figure 1 is available at International Immunology Online). These results suggest that elevated histamine in Ahr À/À macrophages amplifies the H1R signaling pathway resulting in IL-6 production.
Discussion
In this study, we have demonstrated that Ahr functions as a negative regulator of LPS-induced HDC expression, which leads to suppression of histamine production in macrophages. We have also shown that loratadine and chlorpromazine inhibit LPS-induced IL-6 production in Ahr À/À macrophages in a dose-dependent manner. Taken together, Ahr controls another pathway for IL-6 production different from a pathway of NF-jB activation via MyD88 through inhibition of histamine production in macrophages (Fig. 6) . 
001). (C) WT and Ahr
À/À macrophages or RAW/Neo and RAW/Ahr cells were stimulated with 1 lg ml À1 LPS for 24 h. Sp1-binding activity was examined using the Sp1 TransAM assay. Data show means 6 SD of three independent experiments (**P < 0.002). (D) RAW/Neo and RAW/Ahr cells were stimulated with 1 lg ml À1 LPS for 24 h and the ChIP assay was performed using anti-Sp1 and anti-IgG (negative control) antibodies. Purified DNA fragments were amplified using primers specific for the mouse HDC promoter. Data are from one representative of three independent experiments.
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Recent studies have demonstrated that the C/EBPb and Sp1 transcription factors are essential for LPS-induced HDC expression in macrophages (20, 36) . In particular, the LPSinduced binding of Sp1 to the GC box region in the HDC promoter induces the expression of HDC in mice (20) . In the present study, we found that Ahr activated by LPS inhibits LPS-induced HDC expression through association with Sp1 (Figs 1 and 2A) . In contrast, it was reported that Ahr activated by TCDD bound to XRE elements in the CYP1A1 gene, which induced CYP1A1 expression through cooperation with Sp1 (23). However, no obvious XRE sequences were found around the 5-kb regions upstream or downstream of the Sp1-binding site of the promoter in the mouse HDC gene, suggesting that the mechanism by which AhrSp1 complex regulates LPS-induced HDC expression is different from that of TCDD-induced CYP1A1 expression. Although we previously showed that Ahr plays an essential role in the negative regulation of the LPS signaling pathway through interaction with Stat1 (32), we demonstrated that the regulation of Ahr in LPS-induced HDC expression is independent of Stat1 (Fig. 4) . Thus, Ahr appears to regulate gene expression through interaction with transcription factors such as NF-jB, Stat1 and Sp1 in different manners, i.e. non-canonical (32, 37, 38) .
We also found that Ahr represses LPS-induced activation of the HDC promoter, suggesting that Ahr inhibits Sp1 transcriptional activity. Sp1 phosphorylation has been shown to influence its DNA binding and transcriptional activity (39) (40) (41) . It has been reported that the phosphorylation of Sp1 on Ser 61 by cyclin-dependent kinase enhances Sp1 DNA binding. Sp1 is also phosphorylated on Thr 453 and 739 by p42/44 mitogen-activated protein kinase (MAPK) both in vitro and in vivo, which contributes to increased Sp1 binding to the vascular endothelial growth factor promoter (40, 41) . More recently, it has been shown that the inhibition of p42/44 MAPK activation leads to the suppression of LPS-induced HDC expression and histamine production in RAW264.7 cells (42) . These reports indicate that Sp1 phosphorylation by MAPK activation is required for LPS-induced HDC expression in macrophages. In the present study, we demonstrated that although LPS-induced Ahr does not influence Sp1 protein level, Ahr decreases the levels of LPS-induced Sp1 phosphorylation on Ser residues through interaction with Sp1, which contributes to the attenuation of Sp1 DNA-binding activity after LPS stimulation (Figs 2 and 3) . The mechanism underlying the LPS-induced cross-talk between Ahr and Sp1, however, remains to be investigated in detail. Recent studies have demonstrated cross-talk between the Ahr signaling pathway and MAP kinase pathways (43, 44) . As MAPKs have been shown to play an important role in Sp1 activation downstream of LPS signaling (45) , these reports lead us to hypothesize that the cross-talk between Sp1 and Ahr may be mediated by MAPK activation.
We demonstrated that loratadine and chlorpromazine suppress LPS-induced IL-6 production in Ahr À/À macrophages in a dose-dependent manner, whereas the two compounds do not significantly influence the levels of LPS-induced TNFa, IL-12 or IL-10 ( Fig. 5A and C) . These results suggest that elevated histamine contributes to the increase of IL-6 production via H1R in Ahr À/À macrophages after LPS treatment. Unexpectedly, we found that loratadine and chlorpromazine inhibit LPS-induced IL-6 production in Stat1 À/À macrophages more than that in WT cells at high concentrations ( Fig. 5B and D) , although the differences between the levels of histamine production in Stat1 À/À and WT macrophages were not significant (Fig. 4C) . This finding suggests that histamine may effectively induce IL-6 production via H1R in synergy with other factors such as a pro-inflammatory cytokine TNF-a, which production in Stat1 À/À macrophages is likely to be higher than that in WT macrophages after LPS stimulation ( Fig. 5B and D) . This hypothesis is supported by a report that histamine and TNF-a synergized to induce IL-6 production (12). Moreover, LPS-induced IL-10 production in both Stat1
À/À and Ahr À/À macrophages was much lower than that in WT macrophages (Fig. 5) , suggesting that the inhibition of LPS-induced IL-10 production may also contribute to the elevation of IL-6 production via H1R because it is well known that IL-10 negatively regulates the production of inflammatory cytokines (46) . Consistent with our results, a growing number of studies have recently shown that the production of IL-6 is induced via H1R in macrophages, whereas the production of TNF-a and IL-12 is inhibited and the production of IL-10 is enhanced via H2R (8, (11) (12) (13) (47) (48) (49) (50) . An important finding of the current study is that loratadine and chlorpromazine predominantly inhibit LPS-induced IL-6 production in macrophages, suggesting that the predominant pathway for IL-6 production via H1R exists in À7 to 2 3 10 À5 M) for 30 min and then incubated with 1 lg ml À1 LPS. Levels of mouse IL-6, IL-12, TNF-a and IL-10 in culture supernatants 24 h after stimulation were measured using ELISA. The effects of H1R antagonists at higher concentrations than 2 3 10
À5 M could not be tested because the compounds may exhibit cytotoxicity. Data show means 6 SD of three independent experiments (*P < 0.05, **P < 0.01, ***P < 0.001).
macrophages. At present, however, the detailed mechanism of H1R signaling to IL-6 production remains poorly understood. Triggiani et al. (11) reported that increase of the intracellular Ca 2+ concentrations via H1R was required to elevate IL-6 production in macrophages. It has also been reported that stimulation of Gq-coupled receptors enhanced Ca 2+ -dependent JNK activity compared with Gs-coupled receptors in COS-7 cells (51, 52) . These reports seem to imply that the JNK pathway is involved in the activation of IL-6 production via H1R, a Gq-coupled receptor.
The regulation of histamine receptor expression patterns influences the secretion of pro-inflammatory cytokines. Wang et al. (53) reported that the switch from H2R to H1R during differentiation in the monocyte/macrophage lineage participated in the pathogenic processes of atherosclerosis and inflammatory reactions in the arterial wall. H2R mRNA levels in the liver were reported to be up-regulated by LPS treatment, which might serve as an immunoregulatory function because of anti-inflammatory effects in macrophages (8) . These reports indicate that the up-regulation of H1R expression enhances inflammatory functions in macrophages, although H2R expression may be immunosuppressive. LPS, however, did not appear to influence the level of either H1R or H2R in WT or Ahr À/À macrophages ( Supplementary Fig. 2 is available at International Immunology Online).
In summary, we have demonstrated that Ahr negatively regulates IL-6 production via H1R through suppression of LPS-induced histamine production in macrophages. We have also shown a previously uncharacterized role for Ahr in impairing LPS-induced Sp1 phosphorylation on Ser residues through association with Sp1 in macrophages. However, the detailed mechanism underlying these results requires further investigation. This novel regulatory mechanism provides a new perspective on the use of an Ahr agonist in the treatment of allergic and inflammatory diseases.
Supplementary data
Supplementary data are available at International Immunology Online.
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